Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OS”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Large-scale testing (Phase 3)Study completedNCT04642469
What this trial is testing

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Who this might be right for
Carcinoma, Non- Small Cell Lung
AstraZeneca 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07723976
What this trial is testing

Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

Who this might be right for
Developmental and Epileptic Encephalopathy (DEE)
Jazz Pharmaceuticals 120
Not applicableEnrolling By InvitationNCT07450040
What this trial is testing

Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma

Who this might be right for
ORROSPFS
Eye & ENT Hospital of Fudan University 60
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Not applicableLooking for participantsNCT03200964
What this trial is testing

OS Anesthesia Followup of All Bariatric Procedures at One Hospital

Who this might be right for
Anesthesia Recovery
AZ Sint-Jan AV 20,000
Not applicableUnknownNCT04038034
What this trial is testing

Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma

Who this might be right for
Glaucoma, Open-Angle
VISUfarma SpA 70
Not applicableLooking for participantsNCT06279975
What this trial is testing

Pupillometric Evaluation in Patients Declared Brain Dead - a Prospective Quality Control Study

Who this might be right for
Brain DeathAdults
University Hospital, Basel, Switzerland 50
Not applicableUnknownNCT03807583
What this trial is testing

Plasma Amino Acid Levels After Protein Ingestion or Amino Acid Injection During Dialysis

Who this might be right for
End Stage Renal Disease on Dialysis (Diagnosis)
Indigo Therapeutics 30
Testing effectiveness (Phase 2)UnknownNCT05306405
What this trial is testing

Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream

Who this might be right for
Cervix; Pregnancy
Ain Shams University 120
Not applicableNot Yet RecruitingNCT06228027
What this trial is testing

External Validation os the ACME Scoring System

Who this might be right for
Acute Cholecystitis
Hospital del Mar 10,000
Post-approval studies (Phase 4)UnknownNCT04083066
What this trial is testing

Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Mingzhi Zhang 20
Not applicableStudy completedNCT01259895
What this trial is testing

Effects of Time of Sleep Restriction in Obesity

Who this might be right for
ObesitySleep RestrictionAppetite Regulation+1 more
Federal University of São Paulo 20
Early research (Phase 1)Study completedNCT01478022
What this trial is testing

To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Parent Project, Italy 12
Not applicableEnded earlyNCT03046654
What this trial is testing

Cervical Cerclage Position Throughout the Pregnancy.

Who this might be right for
Cervix Uteri-Diseases
Rambam Health Care Campus 7
Early research (Phase 1)Study completedNCT00645554
What this trial is testing

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Who this might be right for
Pharmacokinetics
Xian-Janssen Pharmaceutical Ltd. 2
Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Testing effectiveness (Phase 2)UnknownNCT00568607
What this trial is testing

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

Who this might be right for
Lymphoma
Fudan University 60
Not applicableLooking for participantsNCT06389552
What this trial is testing

Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

Who this might be right for
Adjuvant Chemotherapy
HK inno.N Corporation 36
Next Page